Truist Securities Maintains Buy on HCA Healthcare, Lowers Price Target to $495
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice TargetHot
Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $535 to $495.
Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $535 to $495.